[go: up one dir, main page]

DE69804994D1 - Arzneimittel enthaltend lipidsenkende verbindungen - Google Patents

Arzneimittel enthaltend lipidsenkende verbindungen

Info

Publication number
DE69804994D1
DE69804994D1 DE69804994T DE69804994T DE69804994D1 DE 69804994 D1 DE69804994 D1 DE 69804994D1 DE 69804994 T DE69804994 T DE 69804994T DE 69804994 T DE69804994 T DE 69804994T DE 69804994 D1 DE69804994 D1 DE 69804994D1
Authority
DE
Germany
Prior art keywords
products containing
medicinal products
containing lipid
reducing compounds
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69804994T
Other languages
English (en)
Inventor
Lieven Baert
Geert Verreck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of DE69804994D1 publication Critical patent/DE69804994D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69804994T 1997-11-03 1998-10-27 Arzneimittel enthaltend lipidsenkende verbindungen Expired - Lifetime DE69804994D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203407 1997-11-03
PCT/EP1998/006998 WO1999022738A1 (en) 1997-11-03 1998-10-27 Compositions of lipid lowering agents

Publications (1)

Publication Number Publication Date
DE69804994D1 true DE69804994D1 (de) 2002-05-23

Family

ID=8228898

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69804994T Expired - Lifetime DE69804994D1 (de) 1997-11-03 1998-10-27 Arzneimittel enthaltend lipidsenkende verbindungen

Country Status (20)

Country Link
US (1) US6342245B1 (de)
EP (1) EP1028730B1 (de)
JP (1) JP2001521899A (de)
KR (2) KR20010023729A (de)
CN (1) CN1278175A (de)
AR (1) AR013739A1 (de)
AT (1) ATE216238T1 (de)
AU (1) AU746890B2 (de)
BG (1) BG104338A (de)
BR (1) BR9814109A (de)
CA (1) CA2307097A1 (de)
DE (1) DE69804994D1 (de)
EE (1) EE200000186A (de)
HU (1) HUP0004139A3 (de)
NO (1) NO20002279D0 (de)
NZ (1) NZ503413A (de)
PL (1) PL340305A1 (de)
SK (1) SK5972000A3 (de)
WO (1) WO1999022738A1 (de)
ZA (1) ZA989997B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2450957A1 (en) 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions of dispersions of drugs and neutral polymers
US20030059487A1 (en) * 2001-09-21 2003-03-27 Niazi Sarfaraz K. Composition and method for the treatment of hypercholesterolemia and hyperlipidemia in mammals
US6455557B1 (en) 2001-11-28 2002-09-24 Elan Pharmaceuticals, Inc. Method of reducing somnolence in patients treated with tizanidine
US20040220240A1 (en) * 2001-11-28 2004-11-04 Pellegrini Cara A. Method of increasing the extent of absorption of tizanidine
AU2004275826A1 (en) * 2003-09-26 2005-04-07 Alza Corporation OROS push-stick for controlled delivery of active agents
KR20060092255A (ko) * 2003-09-26 2006-08-22 알자 코포레이션 고도의 약물적재를 제공하는 약물코팅제 및 그의 제조방법
US20050158382A1 (en) * 2003-09-26 2005-07-21 Evangeline Cruz Controlled release formulations of opioid and nonopioid analgesics
MXPA06003452A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente.
PL1683524T3 (pl) 2003-11-14 2011-06-30 Ea Pharma Co Ltd Stała dyspersja lub preparat farmaceutyczny stałej dyspersji pochodnej fenyloalaniny
AU2005230397B2 (en) * 2004-04-09 2010-04-08 Elanco Animal Health Ireland Limited Intermittent dosing regimen for the treatment of overweight with MTP-inhibitors
WO2005117834A1 (en) * 2004-05-27 2005-12-15 Janssen Pharmaceutica N.V. Solid dispersions of a basic drug compound and a polymer containing acidic groups
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
KR100582347B1 (ko) * 2004-12-30 2006-05-22 한미약품 주식회사 3-하이드록시-3-메틸글루타릴 조효소 ａ 환원효소 억제제및 고혈압 치료제의 복합제제 및 그의 제조방법
JP2008542255A (ja) * 2005-05-27 2008-11-27 ファイザー・プロダクツ・インク 肥満症の治療または体重減量の維持のためのカンナビノイド−１受容体アンタゴニストおよびミクロソームトリグリセリド輸送タンパク質阻害物質の併用
PT1912626T (pt) * 2005-08-08 2016-07-20 Abbvie Deutschland Formas farmacêuticas com biodisponibilidade melhorada
EP1938804A1 (de) * 2006-12-22 2008-07-02 Novartis AG Pharmazeutische Zubereitung enthaltend Neurokinin Antagonist
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
WO2010143199A1 (en) 2009-06-11 2010-12-16 Suven Nishtaa Pharma Private Limited Solid lipid dispersion for aqueous solubility enhancement of poorly water soluble drugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521186A (en) * 1994-10-27 1996-05-28 Janssen Pharmaceutica N.V. Apolipoprotein-β synthesis inhibitors
DE122007000005I2 (de) * 1994-10-27 2008-04-24 Janssen Pharmaceutica Nv Apolipoprotein-b syntheseinhibitoren

Also Published As

Publication number Publication date
BR9814109A (pt) 2000-10-03
CN1278175A (zh) 2000-12-27
CA2307097A1 (en) 1999-05-14
ZA989997B (en) 2000-05-02
AU1157699A (en) 1999-05-24
US6342245B1 (en) 2002-01-29
EP1028730B1 (de) 2002-04-17
BG104338A (en) 2000-12-29
HUP0004139A3 (en) 2002-03-28
WO1999022738A1 (en) 1999-05-14
SK5972000A3 (en) 2000-12-11
JP2001521899A (ja) 2001-11-13
AU746890B2 (en) 2002-05-02
EE200000186A (et) 2001-04-16
NZ503413A (en) 2001-06-29
NO20002279L (no) 2000-04-28
KR20010023661A (ko) 2001-03-26
EP1028730A1 (de) 2000-08-23
ATE216238T1 (de) 2002-05-15
PL340305A1 (en) 2001-01-29
NO20002279D0 (no) 2000-04-28
KR20010023729A (ko) 2001-03-26
AR013739A1 (es) 2001-01-10
HUP0004139A2 (hu) 2002-02-28

Similar Documents

Publication Publication Date Title
ATE248594T1 (de) Irbesartanhaltiges arzneimittel
DK0812195T3 (da) Farmaceutisk sammensætning til piperidinoalkanolforbindelser
ATE208377T1 (de) Substituierte benzylaminopiperloin verbindungen
FI970995L (fi) Farmaseuttisia yhdisteitä
FI971018L (fi) Farmaseuttisia yhdisteitä
PT858325E (pt) Formulacao farmaceutica liofilizada estavel
ATE218536T1 (de) Entzündungshemmende verbindungen
ATE240732T1 (de) Ziprasidonhaltige arzneimittel
ATE202472T1 (de) Arzneimittel enthaltend oxaliplatin
CY2005007I1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
DE69804994D1 (de) Arzneimittel enthaltend lipidsenkende verbindungen
ATE298739T1 (de) Calcylitische verbindungen
ATE192157T1 (de) Therapeutisch verwendbare spiro-azabicyclische verbindungen
ATE193298T1 (de) Therapeutische verbindungen
DE69617041D1 (de) Parasitizide verbindungen
DE69807397D1 (de) Triazinylaminostilben Verbindungen
DE69808403D1 (de) Tetradecachlorcyclohexasilandianon enthaltende Verbindungen
FI954243A7 (fi) Farmaseuttiset yhdisteet
DE69133088D1 (de) Pharmazeutisch wirksame benzochinazolin verbindungen
BR9610214A (pt) Compostos farmacéuticos
NO934145L (no) Farmasöytiske forbindelser
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
FI931251A7 (fi) Farmaseuttisia yhdisteitä
ATE225364T1 (de) Bromotiacumicin verbindungen
FI955968A7 (fi) Annostelija kiinteitä lääkeaineita varten

Legal Events

Date Code Title Description
8332 No legal effect for de